Tetraphase Pharmaceuticals

edit

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

Milestones

edit

• Received $15M in Series A funding. (8/7/08)
  Posted 12/31/08 at 9:16pm

Videos

Screenshots

edit

Traffic Analytics

Compete

Sources

1. Equity Help Desk (equityhelpdesk.com) [edit]